(+)-Kasugamycin is an aminoglycoside, composed of the aza-monosaccharide kasugamine (ring A) attached to 1D-chiro-inositol (ring B). We planned to synthesize protected versions of each of these components and conjoin them with a late-stage glycosylation (Scheme 1). Following glycosylation, attachment of the amidinoformic acid moiety and global deprotection would deliver (+)-kasugamycin. Kasugamine would be systematically synthesized from a chiral epoxide synthon in a sequence highlighting our laboratory's sulfamate-tethered aza-Wacker cyclization. 1Dchiro-inositol is commercially available but would have to be protected prior to glycosylation.